Navigation Links
FierceMarkets Announces Winners of Fierce Innovation Awards: Life Sciences Edition
Date:12/21/2016

FierceMarkets (http://www.fiercemarkets.com) today announced the winners of its inaugural Fierce Innovation Awards: Life Sciences Edition. The goal of the program is to identify and showcase outstanding innovation that is driving improvements and transforming the biotech, digital health, and pharma industries.

Rebecca Willumson, Publisher of FierceBiotech and FiercePharma, said, “We were overwhelmed by the response to our inaugural awards program. Almost 200 applications were received and judges commented that the technology presented and the quality of applications was very impressive. The winners truly embody products and services that are forward thinking and have the greatest opportunity to have a big impact on our industry.”

Winners were announced across 5 distinct categories. The judges ultimately selected 3 companies and their solutions from the pool of individual category winners for special recognition as “Best in Show” winners.

Honorees were selected by a distinguished panel of judges from Amgen, Medidata, Otsuka Pharmaceuticals, Pharmaceutical Development Group, PPD, PwC, Thread Research, Valeo Partners, and Verily. More information about our judges can be found here.

Judges evaluated submissions based on Effectiveness, Technical Innovation, Competitive Advantage, Financial Impact and True Innovation.

The 2016 Fierce Innovation Awards: Life Sciences Winners are:

Biotech Innovation:
Recursion Pharmaceuticals for Computationally Intelligent Phenotypic Screening Platform

Data Analytics/ Business Intelligence:
Covance for Xcellerate® Trial Design

Digital Health Solution:
ContextMedia for The Digital Exam Room Wallboard, Infusion Room Tablet and Patient Mobile Connect

Drug Delivery Technology:
Bicycle Therapeutics for Bicycles® and Bicycle Drug Conjugates®

Technology Innovation:
InCrowd for InCrowd MicroTracker

The Best in Show Winners are:

Best Outsourcing Partner
Covance for Xcellerate® Trial Design

Best Technological Innovation
InCrowd for InCrowd MicroTracker

Best New Product or Service
Recursion Pharmaceuticals for Computationally Intelligent Phenotypic Screening Platform

###
About FierceMarkets

At FierceMarkets, our mission is as clear today as it was at our founding in 2000: be the first place to turn to for information-hungry executives in dynamic industries and a trusted partner for the marketing teams that need to reach them. Back then, we saw the coming power of blogs, web journalism, digital marketing and email communications, and launched our first email newsletter, FierceWireless, to begin fulfilling that mission for the mobile telecommunications industry.

Today, our family of over 100 email newsletter publications and websites carries out that same mission for many more industries and millions of users, while we also evolve to address the latest trends in digital media -- mobile devices, social media, native advertising and content marketing. Regardless of what the next trend may be, however, we remain fiercely committed to independent insights for our readers and marketing success for our customers. Learn more at: http://www.fiercemarkets.com .

Read the full story at http://www.prweb.com/releases/2016/12/prweb13940090.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. NW Bio Announces Initiation Of Trading On The OTCQB Marketplace Starting On Monday Morning, December 19, 2016
2. Sterlitech Announces New Ready to Ship, Fully Assembled Membrane Skid System
3. RURO Announces the Limfinity.io® Cloud, for Life Science Information Management
4. Roche announces termination of 2013 Development, Commercialization and License Agreement with Pacific Biosciences
5. Kalorama Announces "Top Five Next-Generation Sequencing Trends of 2016"
6. Express Scripts Announces Enhancements to Industry Leading SafeGuardRx(SM) Programs
7. Forge Therapeutics Announces Novel Antibiotic Presentation at the American Society of Microbiology Conference on Antibacterial Development
8. Informa Announces Second Annual Clinical and Research Excellence Awards
9. Texas Fertility Center San Antonio Announces Complimentary Ovarian Reserve Testing
10. China Cord Blood Corporation Announces Results of 2016 Annual General Meeting
11. Pittsburgh Life Sciences Greenhouse Announces CEO Succession
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2018)... ... 04, 2018 , ... Power T Handle, LLC, a surgeon-driven, ... Orthopedics This Week during the 2018 National Association of Spine Surgeons (NASS) meeting ... instrument that delivers operating room efficiencies through increased speed and reduced surgeon fatigue ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... software solutions for biopharmaceutical R&D, today announced a new out-of-the-box integration of ... Sartorius, a leading international pharmaceutical and laboratory equipment supplier. This enables the ...
(Date:9/28/2018)... ... 28, 2018 , ... GlycoMark®, Inc. has announced a partnership ... test, the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic ... the GlycoMark test to its network of physicians through its sales organization and ...
(Date:9/27/2018)... ANGELES (PRWEB) , ... September 26, 2018 , ... ... device and biologics manufacturer, debuted its focus® Pedicle Screw System today at the ... Center, September 26-29. , The Nvision focus Pedicle Screw System, which ...
Breaking Biology Technology:
(Date:10/5/2018)... Utah and BOSTON (PRWEB) , ... October 04, ... ... in delivering cloud-based enterprise-class unified communications and collaboration solutions, was present at Microsoft ... support of Office 365 communication solutions. , Microsoft issued a statement about the ...
(Date:10/5/2018)... ... October 04, 2018 , ... High dose of biotin may cause interference ... as cardiac troponin has serious clinical complications. There is an increasing trend of high ... unknown. , High dose of biotin supplement use may continue to increase due ...
(Date:10/3/2018)... ... October 03, 2018 , ... Orbsen ... first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, a second generation stromal cell ... progressive diabetic kidney disease in a four-site, pan-European Phase I/II clinical trial. ...
Breaking Biology News(10 mins):